Liminatus Pharma's total assets for Q2 2026 were $3.40M, an increase of 21.99% from the previous quarter. LIMN total liabilities were $3.10M for the fiscal quarter, a 6.17% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.